FIELD: medicine.
SUBSTANCE: invention relates to compounds or pharmaceutically acceptable salts thereof, constituting prodrugs of ketamine, selected from the following structures:
The invention also relates to a pharmaceutical composition modulating the reaction of the NMDA receptor based on the described compounds.
EFFECT: new compounds and a pharmaceutical composition based thereon are produced, applicable in medicine for treating diseases associated with the NMDA receptor, including depression and pain.
15 cl, 6 tbl, 109 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-PROLIFERATIVE COMPOUNDS AND THEIR APPLICATIONS | 2019 |
|
RU2811969C2 |
| AZABICYCLIC AND DIAZEPINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISORDERS | 2018 |
|
RU2795521C2 |
| RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 |
|
RU2697703C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2019 |
|
RU2817800C2 |
| THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF | 2007 |
|
RU2434872C2 |
| JAK KINASE-MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2529019C2 |
| NEW SUBSTITUTED BIARYL COMPOUNDS AS INDOLAMINE-2,3-DIOXYGENASE (IDO) INHIBITORS | 2018 |
|
RU2786586C2 |
| MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF THEIR APPLICATION | 2019 |
|
RU2797558C2 |
| AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS | 2015 |
|
RU2683309C2 |
| ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | 2012 |
|
RU2611627C2 |
